» Articles » PMID: 27280404

Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review

Overview
Journal PLoS One
Date 2016 Jun 10
PMID 27280404
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Current UNAIDS goals aimed to end the AIDS epidemic set out to ensure that 90% of all people living with HIV know their status, 90% initiate and continue life-long anti-retroviral therapy (ART), and 90% achieve viral load suppression. In 2014 there were an estimated 2.6 million children under 15 years of age living with HIV, of which only one-third were receiving ART. Little literature exists describing retention of HIV-infected children in the first year on ART. We conducted a systematic search for English language publications reporting on retention of children with median age at ART initiation less than ten years in resource limited settings. The proportion of children retained in care on ART and predictors of attrition were identified. Twelve studies documented retention at one year ranging from 71-95% amongst 31877 African children. Among the 5558 children not retained, 4082 (73%) were reported as lost to follow up (LFU) and 1476 (27%) were confirmed to have died. No studies confirmed the outcomes of children LFU. Predictors of attrition included younger age, shorter duration of time on ART, and severe immunosuppression. In conclusion, significant attrition occurs in children in the first 12 months after ART initiation, the majority attributed to LFU, although true outcomes of children labeled as LFU are unknown. Focused efforts to ensure retention and minimize early mortality are needed as universal ART for children is scaled up.

Citing Articles

Incidence of loss to follow-up and its predictors among HIV-infected under-five children after initiation of antiretroviral therapy in West Amhara Comprehensive Specialized Referral Hospitals, Northwest Ethiopia: a multicenter retrospective....

Alemu G, Tesfie T, Abuhay H, Mengistu B, Awoke G, Kefale G BMC Pediatr. 2024; 24(1):615.

PMID: 39342164 PMC: 11438255. DOI: 10.1186/s12887-024-05086-2.


Loss to follow-up and its predictors among children living with HIV on antiretroviral therapy, southern Oromia, Ethiopia: a 5-year retrospective cohort study.

Bankere A, Daba S, Ami B, Gedefa L, Lencha B BMJ Open. 2024; 14(7):e078370.

PMID: 39089715 PMC: 11293378. DOI: 10.1136/bmjopen-2023-078370.


Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange.

Nyakato P, Schomaker M, Boulle A, Euvrard J, Wood R, Eley B Trop Med Int Health. 2024; 29(8):739-751.

PMID: 38961819 PMC: 11795028. DOI: 10.1111/tmi.14030.


Incidence of lost to follow up among HIV-positive children on antiretroviral therapy in Ethiopia: Systematic review and meta-analysis.

Girma D, Abita Z, Lemu L, Asmelash D, Bambo G, Alie M PLoS One. 2024; 19(5):e0304239.

PMID: 38776343 PMC: 11111029. DOI: 10.1371/journal.pone.0304239.


Retention in care of infants diagnosed with HIV at birth: Beyond the diagnostic strategy.

Christie M, du Plessis N S Afr J Infect Dis. 2024; 39(1):589.

PMID: 38628425 PMC: 11019047. DOI: 10.4102/sajid.v39i1.589.


References
1.
Massavon W, Barlow-Mosha L, Mugenyi L, McFarland W, Gray G, Lundin R . Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study. ISRN AIDS. 2014; 2014:852489. PMC: 4003865. DOI: 10.1155/2014/852489. View

2.
Davies M, Pinto J . Targeting 90-90-90--don't leave children and adolescents behind. J Int AIDS Soc. 2015; 18(Suppl 6):20745. PMC: 4670834. DOI: 10.7448/IAS.18.7.20745. View

3.
Ojikutu B, Higgins-Biddle M, Greeson D, Phelps B, Amzel A, Okechukwu E . The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in Nigeria. PLoS One. 2014; 9(7):e100039. PMC: 4116117. DOI: 10.1371/journal.pone.0100039. View

4.
Vermund S, Blevins M, Moon T, Jose E, Moiane L, Tique J . Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One. 2014; 9(10):e110116. PMC: 4203761. DOI: 10.1371/journal.pone.0110116. View

5.
McConnell M, Chasombat S, Siangphoe U, Yuktanont P, Lolekha R, Pattarapayoon N . National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007. J Acquir Immune Defic Syndr. 2010; 54(4):423-9. DOI: 10.1097/QAI.0b013e3181dc5eb0. View